Evidence map›Paper›PMID 41334030›Full record

ArticleAmerican journal of ophthalmology case reports2025

Use of freeze-dried umbilical cord amniotic membrane as a corneal patch graft.

Anna Bistour, David Mrejen, Louis Breyton, Jean-Louis Bourges

Abstract readCase Reports
In one paragraph

Article in American journal of ophthalmology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Anna BistourDepartment of Ophthalmology, Centre Hospitalier Universitaire Cochin, Assistance Publique-Hopitaux de Paris, Université Paris Cité, Paris, France.
David MrejenDepartment of Ophthalmology, Centre Hospitalier Universitaire Cochin, Assistance Publique-Hopitaux de Paris, Université Paris Cité, Paris, France.
Louis BreytonDepartment of Ophthalmology, Centre Hospitalier Universitaire Cochin, Assistance Publique-Hopitaux de Paris, Université Paris Cité, Paris, France.
Jean-Louis BourgesDepartment of Ophthalmology, Centre Hospitalier Universitaire Cochin, Assistance Publique-Hopitaux de Paris, Université Paris Cité, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The use of amniotic membranes for corneal perforation management has been extensively documented, demonstrating significant potential in ocular surface reconstruction. However, their application in emergency settings remains underexplored. This report presents a novel use of freeze-dried umbilical cord amniotic membrane as a corneal patch graft, highlighting its practical benefits in urgent clinical scenarios. Case report: A 64-year-old male presented to the emergency department with a painful, red eye, having a history of penetrating keratoplasty. Slit-lamp examination revealed a severe corneal abscess with a 3 mm-wide paracentral perforation. Emergency surgery was performed using a freeze-dried umbilical cord amniotic membrane (SclerFix, Amtrix®, TBF) with a "mushroom plug and patch" technique, combined with a fresh amniotic membrane overlay. Postoperative treatment included oral antibiotics, topical antifungal agents, and antibiotic eye drops. The fresh amniotic membrane dissolved within days, while the freeze-dried umbilical cord membrane facilitated rapid re-epithelialization, effectively sealing the perforation. At three months postoperatively, the cornea remained intact without recurrence or complications, and the patient reported complete pain resolution. Conclusions: This case demonstrates the successful use of freeze-dried umbilical cord amniotic membrane as a corneal patch graft, avoiding emergency keratoplasty and preserving ocular integrity. This technique represents a promising alternative in situations where corneal grafts are not readily available. Further studies are warranted to validate its efficacy.

Identifiers

PMID41334030
PMCPMC12666431

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.